MDLinx Neuro Brief

First-of-its-kind therapeutic for dangerous neurodegenerative symptom, common neuro condition causes memory loss, and a new way to improve drug adherence

It’s not often that the worlds of neurology, pulmonology, and oncology come together all at once, but this week, we’re bringing you a story that makes it happen, with an interesting set of benefits for all three specialties. That’s not all, though—we’ve got brand new bona fides for one of the most-prescribed migraine drugs, new…

New study discredits a decade of research, a first-of-its-kind MS therapy, and a new Alzheimer’s risk factor

This week, researchers added tons of new options to the neurologist’s diagnostic and preventive toolkit, including a simple algorithm to predict Parkinson’s disease risk, more robust data on common risk factors, and new biomarkers. But that’s not all. This week, we highlight several new treatments you’ll want to try (including the first self-administered B-cell therapy…

Migraines linked to dangerous neurodegenerative disease, a diet for your brain, and a new risk factor for a common neurological condition

There’s a lot we still don’t know about COVID-19, but as time goes on the picture becomes a bit clearer. Unfortunately, it’s a pretty grim one. The virus has killed more than 775,000 people worldwide, damaged economies, and even those who survive tell stories of serious downstream difficulties, including some that affect cognition. In this…

×